European ScreeningPort provides:

• deep scientific insight and established links with world class research institutions
• wide ranging industry experience across target classes and therapeutic areas
• access to high quality compound libraries and state-of-the-art screening facilities
• Pharma-scale medicinal chemistry and bioinformatics infrastructure and processes, without the need for capital investments  
• a pragmatic approach to intellectual property that encourages innovation and reinforces collaborative working.  
• co-ordination of SAR seeking and medicinal chemistry programs by leveraging the world-class facilities of its partners